Lavipharm S.A. (ATH:LAVI)
Greece
· Delayed Price · Currency is EUR 1.530
+0.080 (5.52%)
Apr 28, 2026, 5:11 PM EET
Lavipharm Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 62.58 | 52.95 | 47.84 | 39.06 | 39.72 | Upgrade
|
| Revenue Growth (YoY) | 18.20% | 10.68% | 22.48% | -1.68% | 5.54% | Upgrade
|
| Cost of Revenue | 32.28 | 27.87 | 25.69 | 21.44 | 23.84 | Upgrade
|
| Gross Profit | 30.31 | 25.08 | 22.15 | 17.62 | 15.89 | Upgrade
|
| Selling, General & Admin | - | 20.9 | 18.11 | 15.31 | 14.48 | Upgrade
|
| Research & Development | - | 0.63 | 0.43 | 0.85 | 0.81 | Upgrade
|
| Other Operating Expenses | 20.96 | -1.69 | -1.11 | -2.4 | -4.91 | Upgrade
|
| Operating Expenses | 20.96 | 19.84 | 17.43 | 13.56 | 11.38 | Upgrade
|
| Operating Income | 9.35 | 5.24 | 4.72 | 4.07 | 4.51 | Upgrade
|
| Interest Expense | -1.85 | -2.01 | -2.17 | -0.72 | -1.83 | Upgrade
|
| Interest & Investment Income | - | 0.15 | 0.27 | 0.03 | 0.02 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 0.02 | 0.05 | -0.02 | 0 | Upgrade
|
| Other Non Operating Income (Expenses) | - | -0.07 | -0.06 | -0.92 | - | Upgrade
|
| EBT Excluding Unusual Items | 7.5 | 3.33 | 2.81 | 2.44 | 2.7 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | -0.24 | -0.48 | - | -0.02 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 0.36 | 0.43 | - | - | Upgrade
|
| Asset Writedown | - | 0.16 | 0.37 | - | 0.11 | Upgrade
|
| Other Unusual Items | - | - | 0.09 | -0.18 | -0.05 | Upgrade
|
| Pretax Income | 7.5 | 3.6 | 3.22 | 2.26 | 2.75 | Upgrade
|
| Income Tax Expense | 2.45 | -5.06 | 1.25 | 1.31 | 1.02 | Upgrade
|
| Earnings From Continuing Operations | 5.05 | 8.66 | 1.97 | 0.95 | 1.73 | Upgrade
|
| Earnings From Discontinued Operations | 0.94 | 0.32 | -0.1 | -0.12 | - | Upgrade
|
| Net Income to Company | 5.99 | 8.98 | 1.87 | 0.83 | 1.73 | Upgrade
|
| Minority Interest in Earnings | - | 0 | 0 | 0 | -0.01 | Upgrade
|
| Net Income | 5.99 | 8.98 | 1.87 | 0.83 | 1.72 | Upgrade
|
| Net Income to Common | 5.99 | 8.98 | 1.87 | 0.83 | 1.72 | Upgrade
|
| Net Income Growth | -33.31% | 380.06% | 124.34% | -51.60% | -17.72% | Upgrade
|
| Shares Outstanding (Basic) | - | 168 | 168 | 22 | 17 | Upgrade
|
| Shares Outstanding (Diluted) | - | 168 | 168 | 22 | 17 | Upgrade
|
| Shares Change (YoY) | - | 0.17% | 681.40% | 26.42% | - | Upgrade
|
| EPS (Basic) | - | 0.05 | 0.01 | 0.04 | 0.10 | Upgrade
|
| EPS (Diluted) | - | 0.05 | 0.01 | 0.04 | 0.10 | Upgrade
|
| EPS Growth | - | 379.94% | -71.35% | -61.71% | -17.72% | Upgrade
|
| Free Cash Flow | - | -5 | -3.77 | -32.27 | 2.19 | Upgrade
|
| Free Cash Flow Per Share | - | -0.03 | -0.02 | -1.50 | 0.13 | Upgrade
|
| Dividend Per Share | - | 0.020 | - | - | - | Upgrade
|
| Gross Margin | 48.42% | 47.37% | 46.30% | 45.12% | 40.00% | Upgrade
|
| Operating Margin | 14.94% | 9.90% | 9.86% | 10.41% | 11.35% | Upgrade
|
| Profit Margin | 9.57% | 16.96% | 3.91% | 2.14% | 4.34% | Upgrade
|
| Free Cash Flow Margin | - | -9.45% | -7.87% | -82.63% | 5.52% | Upgrade
|
| EBITDA | 13.18 | 9.07 | 8.27 | 4.96 | 5.36 | Upgrade
|
| EBITDA Margin | 21.06% | 17.13% | 17.30% | 12.69% | 13.48% | Upgrade
|
| D&A For EBITDA | 3.83 | 3.83 | 3.56 | 0.89 | 0.85 | Upgrade
|
| EBIT | 9.35 | 5.24 | 4.72 | 4.07 | 4.51 | Upgrade
|
| EBIT Margin | 14.94% | 9.90% | 9.86% | 10.41% | 11.35% | Upgrade
|
| Effective Tax Rate | 32.69% | - | 38.78% | 57.95% | 37.09% | Upgrade
|
| Revenue as Reported | 62.58 | - | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.